Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Aguilar-Company, J
131  Ergebnisse:
Personensuche X
?
1

P1.12-04 The FLARE score and circulating neutrophils are as..:

Seguí, E. ; Gorria, T. ; Auclin, E....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S112 , 2022
Link: https://doi.org/10.1016/..
 
?
2

Co-infections and superinfections complicating COVID-19 in ..:

Gudiol, C. ; Durà-Miralles, X. ; Aguilar-Company, J....
Journal of Infection.  83 (2021)  3 - p. 306-313 , 2021
Link: https://doi.org/10.1016/..
 
?
3

ESCMID Study Group for Infections in Compromised Hosts (ESG..:

Aguilar-Company, J. ; Fernández-Ruiz, M. ; García-Campelo, R...
Clinical Microbiology and Infection.  24 (2018)  - p. S41-S52 , 2018
Link: https://doi.org/10.1016/..
 
?
4

Impact of SARS-CoV-2 vaccines and recent chemotherapy on CO..:

Vincenzi, Bruno ; Cortellini, Alessio ; Mazzocca, Alessandro...
Therapeutic Advances in Medical Oncology.  16 (2024)  - p. , 2024
Link: https://doi.org/10.1177/..
 
?
5

Previous immune checkpoint inhibitor therapy is associated ..:

Mostaghim, Anahita ; Minkove, Samuel ; Aguilar-Company, Juan...
International Journal of Infectious Diseases.  139 (2024)  - p. 13-20 , 2024
Link: https://doi.org/10.1016/..
 
?
6

A two-step algorithm avoids corticosteroids in two-thirds o..:

Barciela, Mar Riveiro ; Barreira, Ana ; Salcedo, María-Teresa...
Journal of Hepatology.  78 (2023)  - p. S375-S376 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Cell-Surface Receptors: EGFR- and VEGFR-Targeted Agents:

, In: Infectious Complications in Biologic and Targeted Therapies,
Aguilar-Company, Juan ; Ruiz-Camps, Isabel - p. 153-172 , 2022
Link: https://doi.org/10.1007/..
 
?
8

COVID-19 Sequelae and the Host Proinflammatory Response: An..:

Cortellini, Alessio ; Gennari, Alessandra ; Pommeret, Fanny...
JNCI: Journal of the National Cancer Institute.  114 (2022)  7 - p. 979-987 , 2022
Link: https://doi.org/10.1093/..
 
?
9

Immune checkpoint inhibitor therapy and outcomes from SARS-..:

Cortellini, Alessio ; Dettorre, Gino M ; Dafni, Urania...
Journal for ImmunoTherapy of Cancer.  10 (2022)  11 - p. e005732 , 2022
Link: https://doi.org/10.1136/..
 
?
10

Real-Life Use of Ceftolozane/Tazobactam for the Treatment o..:

Bergas, Alba ; Albasanz-Puig, Adaia ; Fernández-Cruz, Ana...
Microbiology Spectrum.  10 (2022)  3 - p. , 2022
Link: https://doi.org/10.1128/..
 
?
11

Vaccination against SARS-CoV-2 protects from morbidity, mor..:

Pinato, David J. ; Ferrante, Daniela ; Aguilar-Company, Juan...
European Journal of Cancer.  171 (2022)  - p. 64-74 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Multidisciplinary approach to treatment with immune checkpo..:

Aguilar-Company, Juan ; Lopez-Olivo, Maria A. ; Ruiz-Camps, Isabel
Frontiers in Medicine.  9 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
13

Natural immunity to SARS-CoV-2 and breakthrough infections ..:

Cortellini, Alessio ; Aguilar-Company, Juan ; Salazar, Ramon...
British Journal of Cancer.  127 (2022)  10 - p. 1787-1792 , 2022
Link: https://doi.org/10.1038/..
 
?
14

Long-term treatment with nebulized colistin in oncological ..:

Suanzes, Paula ; Aguilar-Company, Juan ; Rodríguez-González, Esther...
Medicina Clínica (English Edition).  159 (2022)  9 - p. 432-436 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Persistence of long-term COVID-19 sequelae in patients with..:

Cortellini, Alessio ; Salazar, Ramon ; Gennari, Alessandra...
European Journal of Cancer.  170 (2022)  - p. 10-16 , 2022
Link: https://doi.org/10.1016/..
 
1-15